Notable Publications

PUBLICATIONS BY THE ISCL

Click for PubMed Search of ISCL Publications

Olsen EA, Whittaker S, Kim YH et al. Clinical Endpoints and Response Criteria in Mycosis Fungoides and Sézary Syndrome:  a Consensus Statement of the International Society for Cutaneous Lymphomas (ISCL), the United States Cutaneous Lymphoma Consortium (USCLC) and the Cutaneous Lymphoma Task Force of the European Organization for Research and Treatment of Cancer (EORTC). J Clin Oncol. Jun 20, 2011; 29(18): 2598–2607.

Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC).BLOOD. Sep 15; 110(6):1713-22. Epub 2007 May 31.

Kim YH, Willemze R, Pimpinelli N, et al. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC).
BLOOD. 2007 Jul 15; 110(2):479-484.

Pimpinelli N, Olsen EA, Santucci M, et al. Defining early mycosis fungoides. J Am Acad Dermatol. 2005 Dec; 53(6):1053-1061.

Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: Report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol. 2002 Jan; 46(1):95-106.

 

NON-ISCL ARTICLES OF PARTICULAR IMPORTANCE FOR ISCL MEMBERS

Click for PubMed Search of Cutaneous Lymphoma Publications

Olsen EA, Rook AH, Zic J et al. Sézary Syndrome: Immunopathogenesis, Literature Review of Therapeutic Options and Recommendations for Therapy by the United States Cutaneous Lymphoma Consortium (USCLC). J Am Acad Dermatol. 2011 Feb; 64(2):352–404.

Proceedings available from 2009 Cutaneous Lymphoma Summit (October 9-11, 2009, NYC)

Dummer R, Dreyling M; ESMO Guidelines Working Group. Primary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment, and follow-up. Ann Oncol. 2008 May; 19 Suppl 2:ii72-6.

Urosevic M, Fujii K, Calmels B, et al. Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas. J Clin Invest. 2007 Oct; 117(10):2834-46.

Trautinger F, Knobler R, Willemze R, et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome. Eur J Cancer. 2006 May; 42(8):1014-30. Epub 2006 Mar 30.

Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. BLOOD. 2005 May 15; 105(10):3768-3785.

Burg G, Kempf W, Cozzio A, et al. WHO-EORTC classification for cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol. 2005;32:647-674.

OTHER PUBLICATIONS OF INTEREST

Urosevic M, Fujii K, Calmels B, et al. Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas. J Clin Invest. 2007 Sep 6; [Epub ahead of print]
(Download Publication in PDF Format)

Dummer R. Primary cutaneous lymphomas: ESMO Clinical Recommendations for diagnosis, treatment, and follow-up. Annals of Oncology. 2007 May;18 Suppl 2:ii61-ii62.
(Download Publication in PDF Format)